Actively Recruiting
Multifocal Theta-Burst Stimulation to Enhance Upper Limb Motor Recovery After Stroke (INSPIRE)
Led by School of Health Sciences Geneva · Updated on 2026-02-27
46
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
Sponsors
S
School of Health Sciences Geneva
Lead Sponsor
U
University Hospital, Geneva
Collaborating Sponsor
AI-Summary
What this Trial Is About
Stroke is one of the leading causes of long-term disability worldwide. Many individuals who survive a stroke continue to experience weakness and reduced control of one arm, even months or years after the event. These motor impairments significantly affect independence, daily activities, and quality of life. Despite rehabilitation efforts, recovery of upper limb function remains incomplete for many patients. Motor recovery after stroke depends on the brain's ability to reorganize itself, a process known as neuroplasticity. Recent research suggests that motor learning and brain recovery are influenced not only by activity in the primary motor cortex (M1), but also by its functional connectivity with other brain regions, particularly the parietal cortex (PC). Strengthening communication between these regions may enhance motor recovery. This study aims to investigate a novel, non-invasive brain stimulation approach called intermittent theta-burst stimulation (iTBS). Unlike traditional stimulation methods that target a single brain region, this study uses a multifocal stimulation protocol targeting both the primary motor cortex and the parietal cortex. The stimulation is combined with structured motor training using an interactive tablet-based rehabilitation device (REAtouch®Lite 2), designed to improve arm movement through goal-directed reaching tasks. The study is a single-center, randomized, sham-controlled, triple-blind clinical trial with parallel groups. Thirty-six individuals with chronic stroke-related upper limb impairment will be randomly assigned to receive either active multifocal iTBS or sham (placebo) stimulation. Both groups will complete identical motor training sessions. In addition, ten healthy participants will complete the same motor training protocol (without brain stimulation) to provide reference data. Participants will attend six visits over approximately 10 days. Assessments will include motor performance tests using the interactive tablet, a standardized clinical motor scale (Fugl-Meyer Assessment for Upper Extremity), and resting-state electroencephalography (EEG) to measure brain connectivity changes. The primary outcome is improvement in motor performance between baseline and one week after the intervention. Secondary outcomes include short-term motor improvements, retention of learning, changes in movement quality, and changes in brain functional connectivity. This study seeks to determine whether combining multifocal brain stimulation with targeted motor training can enhance motor learning and promote better recovery of arm function after stroke. If effective, this approach could contribute to the development of more precise, network-based neurorehabilitation strategies.
CONDITIONS
Official Title
Multifocal Theta-Burst Stimulation to Enhance Upper Limb Motor Recovery After Stroke (INSPIRE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Stroke participants aged 18 years or older
- First-ever ischemic or hemorrhagic stroke
- Stroke occurred at least 6 months ago
- Unilateral upper limb weakness (hemiparesis)
- Fugl-Meyer Assessment Upper Extremity score between 29 and 57
- Modified Ashworth Scale score less than 2 at elbow, wrist, or finger flexors
- Manual muscle testing score of 3 or higher in proximal upper limb muscles
- Ability to understand and follow study procedures
- Provided written informed consent
- Healthy participants aged 18 years or older
- No history of neurological disease (for healthy participants)
- Ability to understand and follow study procedures (for healthy participants)
- Provided written informed consent (for healthy participants)
You will not qualify if you...
- Second stroke during the study period
- Botulinum toxin injection within 3 months before the study
- History of epileptic seizures
- Metallic objects near the brain stimulation site
- Implanted electronic or metallic devices incompatible with brain stimulation (e.g., pacemaker, neurostimulator)
- Severe other conditions affecting the upper limb (traumatic, rheumatologic, osteoarticular, neurodegenerative)
- Pregnancy
- Delirium or impaired alertness
- Inability to participate in one-hour treatment sessions
- Inability to comply with study procedures (language barrier, psychological disorder, dementia)
- Current or past substance abuse, including excessive alcohol use
- Participation in another interventional clinical trial within 30 days before enrollment
- For healthy participants: severe musculoskeletal or neurological conditions affecting the non-dominant upper limb
- Pregnancy
- Delirium or impaired alertness
- Inability to participate in one-hour treatment sessions
- Inability to comply with study procedures
- Current or past substance abuse, including excessive alcohol use
- Participation in another interventional clinical trial within 30 days before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University School of Health ▪ HES-SO Genève
Carouge, Canton of Geneva, Switzerland, 1227
Actively Recruiting
Research Team
P
Pierre Nicolo, PhD
CONTACT
N
Nicolas Nicastro, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here